Published in Medical Letter on the CDC and FDA, February 4th, 2007
AMO still intends to file a premarket approval (PMA) application for the Tecnis Multifocal IOL next month in accordance with its original plan to launch the product in the U.S. in the first half of 2008. However, in light of the latest questions raised by the FDA, the company now believes there is a reasonable likelihood the launch timeline could be extended by approximately...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA